menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.

Injunctive Relief Information


AmerisourceBergen has agreed to a nationwide settlement that resolves most of the opioid-related lawsuits filed by state and local government entities across the country. As part of the agreement, court-ordered injunctive relief will apply to each distributor’s Controlled Substance Monitoring Program. The injunctive relief terms will go into effect on July 1, 2022. This webpage provides all of the information and resources to ensure that all of our independent retail, chain retail and mail order pharmacy customers are prepared for the new requirements.

Frequently Asked Questions

What’s changing and what to expect

Injunctive relief letter from AmerisourceBergen

Injunctive relief letter from AmerisourceBergen, McKesson and Cardinal Health

Report an issue related to the diversion of controlled substances.

Use our Reporting Hotline to confidentially report any concerns.